Hemicholinium-3 (HC-3) was administered intraperitoneally to mice concurrently with the intraperitoneal administration of physostigmine or neostigmine. HC-3 increased the LD50 values for both physostigmine and neostigmine but did not alter the effect on brain ACh levels produced by these agents. Since HC-3 does not cross the blood brain barrier after intraperitoneal administration, the antidoting action of HC-3 is peripherally mediated and does not solely involve an inhibition of ACh synthesis. The increase in brain acetylcholine caused by neostigmine was related to a reduction in acetylcholinesterase activity, providing evidence that intraperitoneally administered neostigmine crosses the blood-brain barrier.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Deadly Nightshade (Atropa belladonna) and Other Weed Poisonings in the Pediatric Intensive Care Unit: Analysis of 54 Children.
Turk Arch Pediatr
November 2024
T. C. University of Health Sciences, Van Training and Research Hospital, Pediatrics Clinic, Van, Türkiye.
Article Synopsis
- The study focused on analyzing cases of poisoning from Atropa belladonna (deadly nightshade) among children, reviewing records from January 2010 to January 2022.
- Out of 54 children admitted for poisoning, 24 (44.4%) cases were due to deadly nightshade, presenting symptoms like flushing, vomiting, and severe cases requiring mechanical ventilation.
- The research highlighted key differences in symptom severity between deadly nightshade and other weed poisonings, with significant effects on ICU stay duration and respiratory support needs, yet no fatalities were reported.
Pharmacological Prevention of Postoperative Delirium in Adults: A Review of Recent Literature.
Curr Neurol Neurosci Rep
December 2024
Department of Anesthesiology and Perioperative Medicine, Division of Cardiac and Vascular Anesthesia, Penn State Health, Hershey, PA, USA.
Article Synopsis
- Postoperative delirium (POD) is a common issue for surgical patients that can result in cognitive problems, poorer outcomes, and higher healthcare costs, highlighting the need for strategies to reduce its occurrence.
- Recent studies have investigated various medications, with dexmedetomidine showing the most potential in preventing POD, although its optimal dosing and timing remain unclear; other drugs like acetaminophen and melatonin also need further exploration.
- Additionally, techniques like reducing anesthetic depth and using regional anesthesia are being considered, but they currently lack enough evidence to make strong recommendations, indicating a need for future research on these intervention strategies.
Dual Toxidrome of Anti-cholinergic Storm and Neuroleptic Malignant Syndrome: A Therapeutic Challenge Overcome by Intrathecal Neostigmine.
Neurohospitalist
October 2024
Department of Internal Medicine, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.
Anticholinergic toxicity and neuroleptic malignant syndrome (NMS) are common toxidromes in medical emergencies. However, their co-occurrence, resulting in a dual toxidrome, is rare and presents significant diagnostic and therapeutic challenges. We present the case of a 23-year-old young male with polysubstance dependence, admitted following combined trihexyphenidyl and risperidone toxicity.
View Article and Find Full Text PDFArticle Synopsis
- The study investigates how intramuscular injections of two drugs, physostigmine and neostigmine, affect Na,K-ATPase activity in rat red blood cells after intense exercise.
- Both drugs help reduce stress responses by lowering indicators such as adrenal ascorbic acid, stress-related red blood cell increases, and lipid peroxidation (LPO) markers.
- The drugs appear to restore Na,K-ATPase activity affected by stress and can correct the functions of cholinergic systems in the body’s stress response mechanisms.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!